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Abstract Neuropeptide Y (NPY) and polypeptide YY (PYY) 
are two ubiquitous neuropeptides, found in brain and intestines, 
respectively, where they exert important regulatory functions. In 
this study, a new member of the YY family recently isolated from 
amphibian skin, skin-PYY (SPYY), is reported to inhibit irre- 
versibly the proliferation of a broad spectrum of pathogenic mi- 
croorganisms. NPY and PYY are shown to be endowed with the 
same activity. Their potency is similar to that of other anti- 
bacterial peptides which have been shown to exert their function 
by disintegrating the bacterial membrane. These findings and the 
fact that the C-terminal alpha-helical domain SPYYI4-36, which 
is highly conserved among the family members, was responsible 
for killing microorganisms and for permeation of phospholipid 
vesicles, suggested that the antibiotic activity may emerge via a 
membrane permeation mechanism. These findings also raise the 
question whether NPY and PYY exert in vivo a similar function 
in mammals. 
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1. Introduction 
NPY [1] and PYY [2] are two 36 residues related peptides, 
found at high concentrations in the brain and in the lining of 
the gastrointestinal tract, respectively. They possess common 
features of tertiary structure, known as the PP-fold [3]. The 
PP-fold, as characterized by X-ray diffraction analysis of crys- 
tals, consists of two antiparallel helices: an N-terminal polypro- 
line helix spanning residues 1-14, and a long amphipathic C- 
terminal alpha-helix. In mammals, these peptides are involved 
in a variety of important regulatory functions, e.g. sympathetic 
vascular control, central regulation of endocrine and auto- 
nomic function, food intake, circadian rhythm, etc., and are 
believed to induce their various biological effects by activating 
specific membrane bound receptors, Yt and/or Y2 [4]. However, 
numerous experimental discrepancies raised the possibility that 
additional subtypes of Y-receptors exist [5,6]. Likewise, various 
atypical (Yl- and Y2-independent) activities remain ill-under- 
stood phenomena such as, histamine release from isolated mast 
cells, or increase of intracellular Ca 2+ in many cell types. 
Recently, during the search for new antibiotic agents, chro- 
matography of skin extract of the South American tree-frog Phyl- 
lomedusa bicolor, displayed three distinct antifugal fractions [7]. 
The activity of two of these fractions was shown to be due to 
two closely related peptides belonging to the dermaseptin fam- 
ily of antimicrobial peptides [7-10]. Surprisingly however, the 
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antifugal activity of the third fraction was due to a peptide 
whose pharmacological and structural properties closely resem- 
bled those of NPY and PPY (72% and 94% amino acid posi- 
tional identity, respectively) and thus termed Skin-PYY 
(SPYY) [11]. 
To confirm this unexpected antimicrobial ctivity, we inves- 
tigated in this study, the ability of synthetic SPYY to affect the 
viability of various prokaryotic and eukaryotic ells in culture 
media. The data established that at micromolar concentrations 
SPYY behaves as a large spectrum antibiotic agent. Moreover, 
the concept was extended to other SPYY related peptide, NPY 
and PYY, which exhibited similar antimicrobial properties. A
possible mode of action is discussed. 
2. Materials and methods 
2.1. Peptides 
Peptides were prepared by stepwise solid-phase synthesis using fluo- 
ren-9-ylmethoxycarbonyl (Fmoc) polyamide active ester chemistry on 
a Milligen 9050 pepsynthesizer asdescribed [11]. Cleavage of peptidyl- 
resin and side-chains deprotection were carried out with a mixture 
composed of trifluoroacetic acid, para-cresol, thioanisol, water and 
ethyl-methyl-sulfide (82.5,5,5,5 and 2.5 v/v). After filtering to remove 
the resin, and ether extraction, the crude peptides were purified by a 
combination of Sephadex gel filtration, ion exchange chromatography 
and preparative HPLC. Homogeneity of the synthetic peptides was 
assessed by analytical HPLC, amino acid analysis, olid phase sequence 
analysis and mass spectrometry. Human NPY and PYY were a gener- 
ous gift of Dr. Hubert Vaudry from University of Rouen, France. 
2.2. Biological assays 
Antimicrobial assays were performed in sterilized 96-well plates 
(Nunc F96 microtiter plates, Denmark) as described [10]. Briefly, the 
synthetic peptides were weighted in a microbalance and solubilized in 
water at the desired primary dilution. Serial 2-fold peptide dilutions in 
water were added to suspensions containing 10 6 spores or microconidia/ 
ml in Sabouraud glucose broth, or  10 6 bacteria/ml inLuria Bertani (LB) 
culture medium. Inhibition of growth was determined by measuring 
optical density at 492 nm with a Titertek Multiskan MCC after an 
incubation time of 24 h at 30°C. Bacteria were incubated at 37°C. 
Reversibility of inhibition was assessed by incubating suspensions 
containing 1 x l06 cells/ml in culture media in presence of peptide con- 
centration of0.2 mg/ml. After various incubation periods, aliquots were 
centrifuged at 900 x g, the pellet washed and reincubated for 24 h in 
fresh culture medium. 
The effect on leishmania parasites was assessed after peptide xpo- 
sure by counting living cells following trypan blue inclusion. Promasti- 
gotes (strain MRHO/SU/59/Neal P.) at the stationary phase of growth 
(1 x 105 cells/ml) were cultured at 26°C in RPMI 1640 complete me- 
dium. Amastigotes (1x 104 cells/ml) were purified from cutaneous le- 
sions of infected Balb/c mice [12] and cultured at 37°C. Promastigote 
proliferation was assessed after 24 h incubation at 26°C in presence or 
absence of SPYY, followed by count of motile cells. 
Hemolytic activity of the synthetic peptides was assayed with hepa- 
rinized fresh human blood rinsed three times with PBS by centrifugation 
for 15 min at 900 x g. Red blood cells (108/ml) were then incubated 
under agitation at 37°C in distilled water for 100% hemolysis, in PBS 
(50 mM sodium phosphate, 150 mM NaC1, pH 7) for control or in PBS 
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containing various concentrations of the peptide in a final volume of 
0.2 ml. Release of hemoglobin was monitored after centrifugation at
900 × g by measuring the absorbance of 100 ~1 of supernatant a 541 
nm after up to 24 h of incubation. 
Toxicity against murine macrophages: macrophages were obtained 
by wash of peritonal cavity of Balb/c mice with 10 ml Dulbecco's 
modified Eagle's medium (DMEM, Gibco) as described [13]. Resident 
cells were allowed to adhere for 3 h at 37°C-5% CO2 in 8-well plates 
(Lab-Tek) at 2 x 105 cells/well, then thoroughly washed to remove non- 
adherent cells and incubated with various SPYY concentrations. After 
24 h incubation, the viability of treated macrophage was assessed after 
trypan blue inclusion by counting the live cells. 
2.3. Membrane permeation 
Small unilamellar vesicles (SUV) were prepared by sonication of 
PC/PS (1:1 w/w) and cholesterol (10% by weight) as described [14]. 
Membrane permeation was assessed using the diffusion potential ssay 
[15] as described [14]. Increasing concentrations of the peptide were 
mixed with SUV that had been pretreated with the fluorescent poten- 
tial-sensitive dye (diS-C2-5) and valinomycin. Recovery of fluorescence 
was monitored as a function of time and usually occurred within 1 to 
10 min. Maximal activity of the peptides was plotted versus peptide/ 
lipid molar ratio. 
3. Results 
The peptide's ability to inhibit cell proliferation is reported 
in terms of minimal inhibitory concentration (MIC), defined as 
the lowest peptide dose at which 100% inhibition of growth was 
observed after 24 h of incubation. As shown in Table 1, at 
peptide concentrations ranging between 10 and 100 pg/ml 
SPYY inhibited the proliferation of a large spectrum of patho- 
genic microorganisms, including bacteria, yeasts and filamen- 
tous fungi. In fact, SPYY had a similar though non-identical 
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Fig. 1. Dose-dependent kinetics of the leishmanicidal effect. Each point 
represents the mean from at least 2 independent experiments performed 
in duplicates. Standard eviations were -< 10%. 
0 
0 
>- 
n- 
uJ 
> 
0 3O 
0 
uJ 
n- 
uJ 
0 
Z ,,, 20 
0 (/) 
Ill 
n- 
O 
. J  
U. 10  
*6 
o~ 
i i 
0.02  0 .04  0 .06  0 .08  0.1 
[Pept ide] / [L ip id ]  
Fig. 2. Membrane permeation effect on acidic PC/PS vesicles. SPYY, 
filled circles; SPYYI,36, squares; Cecropin B1, empty circles; control 
peptide (see legend of Table 2), triangles. Maximal activity of the pep- 
tides was plotted versus peptide/lipid molar atio. Each point represents 
the mean of 3 to 6 separate xperiments with standard eviation of 
+5%. 
spectrum of activity as dermaseptin SI, a well established anti- 
biotic peptide from frog skin (Table 1). Whereas, the two pep- 
tides displayed similar MIC against A. cavias, E. faecalis and 
A. fumigatus, SPYY was less efficient han dermaseptin SI
against E. coli and A. niger, and SPYY was clearly more effi- 
cient against N. brasiliensis, M. canis, T. rubrum and A. simii. 
To verify the reversibility of inhibition, treated suspensions 
were thoroughly washed at various periods and reincubated in 
fresh, SPYY-free culture medium. Washed microorganisms 
that were exposed to SPYY for 24 h, did not proliferate after 
additional 48 h of incubation. These results remained un- 
changed when suspensions were exposed to SPYY for 1 h or 
for 10 rnin. This indicated that the effect was rapid and irrevers- 
ible. 
The antibiotic effect of SPYY was further investigated using 
Leishmania major, the protozoan parasite that is responsible for 
worldwide diseases in man and animals. The parasite's life cycle 
consists of an extracellular p omastigote stage, found in gut of 
sandflies, and an intracellular amastigote stage that occurs 
within the phagolysosomes of macrophages. 
The effect of SPYY on the promastigote form was easily 
observable under light microscope. Upon SPYY addition, the 
motile parasites rapidly ceased to move and became round. 
With time, many cellular debris were observable although the 
shape of the promastigote was not dramatically altered (not 
shown). Yet, 100% promastigotes were found non viable within 
1 h incubation at 25/~g/ml (Fig. 1A). For shorter incubation 
periods, the killing effect was dose dependent. At these concen- 
trations, SPYY inhibited the proliferation of promastigotes a
determined after 24 h incubation. Moreover, the effect was 
irreversible since treated parasites did not recover motility, nor 
did they proliferate after a thorough wash and reincubation 
over 48 h in SPYY-free fresh culture medium. 
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Table 1 
Spectrum of antimicrobial ctivity and toxicity in culture media 
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Organism MIC a ~g/ml) 
SPYY NPY PYY SPYYI~36 DS c 
Aeromonas caviae 60 40 50 
Eseherichia coli 15 - - 10 5 
Enterococcus faecalis 20 10 25 
Nocardia brasiliensis 30 20 100 
Cryptococcus neoJbrmans 25 30 25 20 15 
Candida albicans 25 25 25 15 60 
Microsporum eanis 10 10 50 
Tricophyton rubrum 15 15 1 O0 
Arthroderma simii 15 20 15 10 100 
A spergillus Jumigatus 100 80 100 
A spergillus niger > 1 O0 > 1 O0 1 O0 
Toxicity b(flg/ml) 
Human erythrocytes > 100 > 100 > 100 > 100 >100 
Murine macrophages > 100 > 100 > 100 > 100 > 100 
Minimal inhibitory concentrations for cell proliferation were determined after 24 h incubation. 
b Toxicity was determined after 1 h incubation. Each value was determined from at least 2 independent experiments performed in duplicate. Variations 
were <20%. -, not determined. 
The spectrum of dermaseptin (DS) is shown for comparison [8]. 
In addition, a similar profile was observed in the activity of 
SPYY against he amastigotes form of the parasite (Fig. 1B). 
Albeit, SPYY was less potent against amastigotes than against 
promastigotes, at incubation period shorter than 1 h. 
Interestingly, toxicity was not observed for mammalian 
erythrocytes or macrophages up to peptide concentration of 
100/.tg/ml (Table 1), a concentration that killed a large variety 
of pathogenic microorganisms. 
To further confirm these findings, antimicrobial ctivity was 
investigated for 2 SPYY-related peptides, NPY and PYY, 
under the same experimental conditions. Despite differences in 
primary structure that are located mostly within the N-terminal 
segment (Table 2), both peptides exhibited antibiotic activity 
against microorganisms at comparable concentrations, with no 
toxicity for mammalian cells (Table 1). 
Moreover, a short peptide version of SPYY (SPYY~4-36) rep- 
resenting the C-terminal alpha-helical portion which is highly 
conserved among the PP family members howed that the trun- 
cature of the N-terminal 13 residues did not alter the peptide's 
antimicrobial properties (Table 1). In fact, SPYY~4_36 displayed 
a molar potency comparable to that observed for the parent 
molecule, against most microorganisms a sayed. Conversely, 
the N-terminal fragment SPYY~ ~4 had no antimicrobial ctiv- 
ity against any of the microorganisms a sayed. 
Finally, to gain insight into the mechanism of antimicrobial 
action, we used the Dissipation of Diffusion Potential Assay to 
examine the efficacy of SPYY and its shorter version in per- 
Table 2 
Primary structures of YY peptides assaye& 
NPY 
PYY 
SPYY 
SPYYI4 ~6 
SPYYI 14 
YPSKPDNPGEDAPAEDMARYYSALRHYINL ITRQRY-NH 2 
YP IKPEAPGEAASPEELNRYYASLRHYLNLVTRQRY-NH 2 
YPPKPESPGEDASPEEMNKYLTALRHYINLVTRQRY-NH 2 
PEEMNKYLTALRHYINLVTRQRY-NH 2 
YPPKPESPGEDASP 
To control for any compounds carried over in the peptide preparation, 
a helical polyanionic peptide (EEEKRENEDEEKQDDEQSEM) was 
prepared and used in parallel in all experiments. The effect of the acidic 
peptide was generally equivalent to the untreated control experiments. 
turbing the lipid packing and causing leakage of vesicular con- 
tents, a property that is characteristic of well defined antimicro- 
bial peptides uch as cecropin [16], magainin [17] or derma- 
septin [18,19]. 
Albeit with different potencies, both SPYY and SPYY14_36 
permeated the phospholipid vesicles with a comparable or 
higher efficiency than that observed for cecropin (Fig. 2). 
4. Discussion 
Peptide synthesis and characterization f the final product 
were reported in detail [11] where the identity between the 
synthetic product and the natural SPYY was established. In 
this study, the synthetic replicate was used to confirm the anti- 
fungal activity observed for natural SPYY [7]. Such activity, 
was indeed confirmed and SPYY was furthermore found to 
have antibiotic action over a large spectrum of pathogens. 
Previous tudies have reported that peptide sequences corre- 
sponding to neuropeptide or hormonal fragments, uch as Gas- 
tric Inhibitory Polypeptide7~2 or Diazepam-Binding Inhib- 
itor32 86, were endowed with antimicrobial ctivity [20]. How- 
ever, the synthetic replicates of the said peptides or their parent 
molecules were devoid of such activity. This study reports thus 
for the first time convincing evidence that antibiotic activity is 
associated with otherwise notoriously known gastro-intestinal 
and brain mammalian europeptides. It should be noted that 
antimicrobial activity was reported concerning another neu- 
roactive skin peptide, adenoregulin, a 33-residue amphipathic- 
polycationic peptide that shares no homology with YY pep- 
tides, and that enhances binding of agonists to the A1 ade- 
nosine receptors [21]. Like the YY peptides, adenoregulin also 
acts at specific receptor sites with affinity in the nanomolar 
range, yet adenoregulin exhibited potent antibiotic properties 
at micromolar concentrations [7]. 
It seems unlikely that the mechanism of antimicrobial ction 
exhibited by YY peptides, is mediated by activation of specific 
receptors. Rather, inherent structural properties may be in- 
volved in a concentration dependent manner that may explain 
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other atypical effects of YY peptides. Namely, Shen et al. pro- 
posed that histamine release from isolated mast cells as induced 
by NPY, is associated with non-receptor mediated irect acti- 
vation of G-proteins [22]. However, this does not account for 
cell lysis. On the other hand, studies performed with antimicro- 
bial peptides uch as the dermaseptins, cecropin, or magainin 
indicated that the basicity and amphiphilicity of their alpha- 
helical structure are the responsible f atures for inducing cells 
lysis [23,24]. According to this hypothesis, upon association of 
the peptide at the membrane surface via electrostatic nterac- 
tions, the amphipathic helix penetrates in the membrane and 
perturbs its structure, which results in rapid osmolysis. More- 
over, since peptide-membrane int ractions are governed by their 
respective physico-chemical properties (amphipathy, peptide 
length, charge distribution, lipid composition) it was postulated 
that lack of toxicity towards mammalian cells is due to the 
weak- or lack of interactions between these peptides and mam- 
malian membranes [25,26]. Therefore, one expects that mild 
perturbation of the membrane structure may simply lead in 
some cases to non-fatal cross-membrane leakage of ions and 
other small molecules from high- to low concentration. We 
propose that SPYY, and related YY peptides, may act in a 
similar manner. Concordant with this view are the following 
observations: (i) the antibiotic action of SPYY did not require 
the N-terminal sequence, suffice the C-terminal domain which 
is an amphipathic alpha-helical nd polycationic structure. In 
addition, whereas the C-terminal fragment usually induces the 
opposite ffect of the parent molecule [5], in this study, SPYY 
and SPYY14 36 has the same activity; (ii) both SPYY and 
SPYY14_36 were able to perturb the structure of PS/PC vesicles 
and to permeated them, yet SPYY~4-36 was more efficient han 
the parent peptide; (iii) their potency is similar to that of other 
antibacterial peptides such as dermaseptin, cecropin and 
magainin which have been shown to exert their function by 
disintegrating microbial membrane; (iv) the time required to 
induce their antibiotic effect was short (< 10 min) and irrevers- 
ible. 
In conclusion, SPYY and its related peptides may represent 
a promising alternative in the search for new non-toxic, large 
spectrum antibiotic agents. Nevertheless, skin secretions of am- 
phibians have long been considered as a rich source for biolog- 
ically active peptides including hormones and neuropeptides 
[27-29]. Although many of these peptides have identical or 
closely related counterparts in mammalian tissues, their physi- 
ological role in the skin is generally unclear. The results re- 
ported in this study suggest a physiological role for SPYY in 
the protection of amphibians against invading microbes and, 
by extension, raise the question whether SPYY like neuropep- 
tides, i.e. NPY and PYY, do exert a similar function in mam- 
malians and thereby contribute, to an extent, to control germ 
dissemination in their respective tissues of origin where they are 
largely expressed. Interestingly, NPY was found present at very 
high concentrations i  brain of normal humans (about 10 ¢tg/g 
wet tissue), exceeding those of CCK, VIP or somatostatin, 
hitherto considered to be the most abundant peptides in the 
nervous ystem [30]. Therefore, the fact demonstrated in this 
study, that at the low ¢tg/ml evel NPY killed 100% of the l0  6 
microorganisms in artificial culture medium, suggests that 
physiologically, the peptide could reach high concentrations 
that are effective for antimicrobial activity. However, such 
physiological role for YY peptides remains to be demonstrated. 
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